Pensa Pharma TOWA PHARMACEUTICAL CO., LTD. Is alreday the new owner of Pensa Pharma Gmbh We only use our own technical cookies to carry out the transmission of communications through a network of electronic communications or, to the extent that is strictly necessary, for the provision of information society services expressly requested by the user, processing data necessary for such purposes . The use of these cookies does not require the user's consent (art. 22.2 LSSICE). UNDERSTOOD MORE INFORMATION ï¿½ber uns: Pensa Pharma "The operation for which Towa has acquired the generics bussiness from Esteve genï¿½ricos materializad on January 30, 2020 and culminated in a visit by Mr. Yoshida, president of Towa, to the manufacturing plant in Martorelles, where he personally greeted all the employees one by one. Barcelona. 3 de febrero de 2020. TOWA PHARMACEUTICAL CO.,LTD. (Osaka, Japï¿½n) (TOWA) has completed the acquisition of 100% of the generic's bussiness of the spanish pharmaceutical company Esteve, as we advanced last December. With the acquisition pf Pensa, Towa will be able to supplu high quality and value-added generic medicines to patients not only in Japan but also in the rest of the world, through Pensa's spanish manufacturing plant specialized in pellets and its network of subsididiaries in Europe and the US. Towa Pharmaceutical highly values current organization and culture and intends to maintain all the current management to drive further growth of the business in the future. No significant changes are expected to occur after the transaction. Itsuro Yoshida, president of TowA Pharmaceutical, also visited Martorelles manufacturing plant and adressed employees in Spanish, Catalan and English to welcome them to Towa pharmaceutical and to convey to them the satisfaction that this purchase represents for their Project to create a large global company leader in generic and has all Pensa people. After the wellcome, Mr. Yoshida greeted everyone present one by one. About TOWA PHARMACEUTICAL CO., LTD. TOWA PHARMACEUTICAL CO., LTD. (www.towayakuhin.co.jp), a company specializing in generic drugs and based in Kadoma, Osaka (Japan), has been dedicated to the research and development, production, and marketing of generic drugs since 1951. With a team of more than 3,100 employees, its annual sales total 105,104 million yen (as of March 2019). TOWA's shares are listed on the Tokyo Stock Exchange (TSE)." Wofï¿½r wir stehen Pensa Pharma steht fï¿½r preisgï¿½nstige Generika auf hï¿½chstem Qualitï¿½tsniveau. Wir wollen unsere Produkte in erster Linie den Patienten und Krankenkassen ï¿½ber Rabattvertrï¿½ge zur Verfï¿½gung stellen. So tragen wir zu erheblichen Einsparungen im Gesundheitsbereich bei. Dabei werden wir uns zunï¿½chst auf die wichtige Substanzklasse der Protonenpumpeninhibitoren (PPI) konzentrieren, die wir selbst herstellen: Omeprazol, Pantoprazol und Lansoprazol. Weitere Wirkstoffgruppen werden bald folgen. Pensa Pharma hat kï¿½rzlich die Rabattvertragsausschreibungen der Techniker Krankenkasse und der DAK Gesundheit gewonnen. So stehen unsere Produkte nun besonders fï¿½r Patienten dieser Kassen zur Verfï¿½gung. Service fï¿½r Apotheken Pensa Pharma wird versuchen, ï¿½ber mï¿½glichst breite Aufstellung in mï¿½glichst vielen Rabattvertrï¿½gen prï¿½sent zu sein. Damit soll eine breite Abgabefï¿½higkeit der Pensa-Produkte in mï¿½glichst vielen Rabattvertrï¿½gen und damit Reduzierung des Lageraufwandes in Apotheken erzielt werden. Bitte bestellen Sie unsere Produkte ï¿½ber Ihren lokalen/regionalen Groï¿½handel! Bei Anfragen zu Rï¿½ckgabekonditionen, etc. wenden Sie sich bitte ebenfalls an Ihren Groï¿½hï¿½ndler. Impressum Verantwortlich fï¿½r den Inhalt gemï¿½ï¿½ ï¿½ 5 TMG und ï¿½ 55 Abs. 2 RStV: Pensa Pharma GmbH, Fï¿½rstenrieder Straï¿½e 105, DE-80686 Mï¿½nchen Vertreten durch: Herr David Peix ï¿½ Geschï¿½ftsfï¿½hrer Kontakt: Pensa Pharma GmbH Tel. +49 (0)89 5682 0168 Fax: +49 (0)89 5682 0172 Email: Umsatzsteuer-ID: Umsatzsteuer-Identifikationsnummer gemï¿½ï¿½ ï¿½27 a Umsatzsteuergesetz: DE 275198669 Pensa Pharma GmbH, Fï¿½rstenrieder Straï¿½e 105, 80686 Mï¿½nchen Tel: +49 (0)89 5682 0168 ï¿½ Fax: +49 (0)89 5682 0172 ï¿½ Geschï¿½ftsfï¿½hrer: David Peix Amtsgericht Mï¿½nchen ï¿½ HRB 188825 ï¿½ Ust-ldNr. DE 275198669 ï¿½ 2007 - 2020 Pensa Pharma Datenschutz | Rechtliche Hinweise | Cookies policy